Category Archives: HIV Prevention

The Global State of Harm Reduction — discrimination, stigma, misunderstanding, misinformation keep response “shockingly low”

By on .

What if there were an evidence-based, cost-effective approach to prevent HIV infections by tackling a risk that accounts for roughly one out of three HIV infections outside of sub-Saharan Africa, and an increasing proportion of HIV infections everywhere? You might think, in the budget-challenged times that donors and recipients in the global health landscape grapple […]

Botswana’s balancing act: A model for AIDS-free generation plans?

By on .

CSIS REPORT EXAMINES ASPIRATIONS AND REALITIES IN COUNTRY’S SUCCESSES AND CHALLENGES Take a country that, a decade ago, grappled with one of the most devastating HIV epidemics in southern Africa. With a population of just over 2 million people, about four out of every 10 adults was infected with the virus that leads to AIDS. […]

Ugandan anti-homosexuality bill makes this International Human Rights Day a time to look at health impacts of homophobic landscapes

By on .

The Ugandan Parliament speaker’s promise to present his country with the “Christmas present” of a revived anti-homosexuality bill has led, in turn to a revived interest in the human rights landscape of that country, three years after the bill with its death penalty provision for “aggravated homosexuality” was first announced. The most recent attention, with […]

Groups seek recognition of global health response “secret weapon”

By on .

When people talk about the how life-saving medicine finally made it to poor countries, how tuberculosis patients far from clinics finished grueling treatment courses, and how 50 million or so newborns made it past infancy over the last 20 years because their mothers, and they, got the treatment they needed, the talk is often of […]

Reports track current progress, pitfalls, funding and gaps of AIDS fight

By on .

On the eve of Secretary Hillary Clinton’s release of the first United States global AIDS response strategy, two reports released in recent days give a look not only of the progress so far, but of the shortfalls the new plan must address. Achieving the End, One Year and Counting, from AVAC, looks at the scientific […]

Study links homophobia, discrimination to prevention, testing, treatment barriers and to attitudes on preventive antiretrovirals

By on .

In the global AIDS epidemic, it is the illustration of a vicious circle: People in situations that leave them the most vulnerable to getting HIV have the least access to protection. They have the highest prevalence of the virus that leads to AIDS. Then they have the least access to care. That may not be […]

HIV prevention: on the verge of transformation

By on .

A look at the recent AIDS Vaccine 2012 Conference shows range of prevention developments The following is a guest post from Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI) and William Snow, director of the Global HIV Vaccine Enterprise. More than 1,000 HIV researchers and other professionals involved in HIV prevention […]

Study reveals effective preventive dose, pain drug for tuberculosis treatment, bad news and new steps in Uganda . . . and more

By on .

New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . .   NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]

Thai trial yield continues with news vaccine changed virus

By on .

The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]

AIDS Vaccine 2012: Of YECIs and generations of work

By on .

BOSTON, MA — When Bill Snow, now director of the Global HIV Vaccine Enterprise, first became interested in the quest for a vaccine against the AIDS virus, he had a life expectancy of less than 10 years, he said Sunday. That was in 1989, he told the audience gathered for the opening of AIDS Vaccine […]